Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland

European Journal of Gynaecological Oncology

Volumn 25, Issue 1, 2004, Pages 93-95

  Menkiszak, J ^a   Rzepka Gorska I ^a   Gorski B ^a   Gronwald, J ^a   Byrski, T ^a   Huzarski, T ^a   Jakubowska, A ^a   Metcalfe, K A ^b   Narod, S A ^b   Lubinski J ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

BRCA1 mutation; Prophylactic oophorectomy

Indexed keywords

ADULT; ARTICLE; BRCA2 ONCOGENE; CANCER PREVENTION; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; ONCOGENE; OVARIECTOMY; OVARY CANCER; POLAND; PROPHYLAXIS;

ADULT; ATTITUDE; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENETIC COUNSELING; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; OVARIECTOMY; POLAND;

EID: 10744231950     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gorski B., Byrski T., Huzarski T., Jakubowska A., Menkiszak J., Gronwald J. et al.: "Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer". Am. J. Hum. Genet., 2000, 66 (6), 1963.
2. Burke W., Daly M., Garber J., Botkin J., Kahn M.J., Lynch P. et al.: "Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium". JAMA, 1997, 277 (12), 997.
3. Eisen A., Rebbeck T.R., Wood W.C., Weber B.L.: "Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer". J. Clin. Oncol., 2000, 18 (9), 1980.
4. Rebbeck T.R., Lynch H.T., Neuhausen S.L., Narod S.A., Van't Veer L., Garber J.E. et al.: "Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations". N. Engl. J. Med., 2002, 346 (21), 1616.
5. Kauff N.D., Satagopan J.M., Robson M.E., Scheuer L., Hensley M., Hudis C.A. et al.: "Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation". N. Engl. J. Med., 2002, 346 (21), 1609.
6. Metcalfe K.A., Liede A., Hoodfar E., Scott A., Foulkes W.D., Narod S.A.: "An evaluation of needs of female carriers undergoing genetic counselling". J. Med. Genet., 2000, 37 (11), 866.
7. Wagner T.M., Moslinger R., Langbauer G., Ahner R., Fleischmann E., Auterith A. et al.: "Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group". Br. J. Cancer, 2000, 82 (7), 1249.
8. Lodder L.N., Frets P.G., Trijsburg R.W., Meijers-Heijboer E.J., Klijn J.G., Seynaeve C. et al.: "One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery)". Breast Cancer Res. Treat., 2002. 73 (2), 97.
9. Lerman C., Hughes C., Croyle R.T., Main D., Durham C., Snyder D. et al.: "Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing". Prev. Med., 2000, 31 (1), 75.
10. Meijers-Heijboer E.J., Verhoog L.C., Brekelmans C.T., Seynaeve C., Tilanus-Linthorst M.M., Wagner A. et al.: "Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation". Lancet, 2000, 355 (9220), 2015.
11. Julian-Reynier C.M., Bouchard L.J., Evans D.G., Eisinger F.A., Foulkes W.D., Kerr B.: "Women's attitudes toward preventive surgeries for hereditary breast or ovarian carcinoma differ from one country to another". Cancer, 2001, 92 (4), 959.
12. Menkiszak J., Gronwald J., Górski B., Jakubowska A., Huzarski T., Byrski T. et al.: "Hereditary ovarian cancer in Poland". Int. J. Cancer, 2003, 106 (6), 942.
13. Warner E., Foulkes W., Goodwin P., Meschino W., Blondal J., Paterson C. et al.: "Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer". J. Natl. Cancer Inst., 1999, 91 (14), 1241.
14. Moslehi R., Chu W., Karlan B., Fishman D., Risch H., Fields A., et al.: "BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer". Am. J. Hum. Genet., 2000, 66 (4), 1259.
15. Thorlacius S., Struewing J.P., Hartge P., Olafsdottir G.H., Sigvaldason H., Tryggvadottir L. et al.: "Population-based study of risk of breast cancer in carriers of BRCA2 mutation". Lancet, 1998, 352 (9137), 1337.
16. De Leon Matsuda M.L., Liede A., Kwan E., Mapua C.A., Cutiongco E.M., Tan A., Borg A. et al.: "BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines". Int. J. Cancer, 2002, 98 (4), 596.
17. Liede A., Malik I.A., Aziz Z., Rios Pd Pde L., Kwan E., Narod S.A.: "Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan". Am. J. Hum. Genet., 2002, 71 (3), 595.